Salman W. Bafageeh

Salman W. Bafageeh

Auto-generated profile, based on publicly available information

Salman W. Bafageeh

Department of Cardiovascular, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2022 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
Uthman AlUthmanUthman AlUthman
Uthman AlUthman
SBSalman W. Bafageeh
Salman W. Bafageeh
MAMohammed A. Ashour
Mohammed A. Ashour
HBHani I. Barnawi
Hani I. Barnawi
ABAbdulbadee A. Bogis
Abdulbadee A. Bogis
AJAhmed A. Jamjoom
Ahmed A. Jamjoom
Hybrid coronary revascularization (HCR) is a technique that merges coronary artery bypass grafting surgery and percutaneous coronary intervention (PCI) approaches for the treatment of multivessel coronary artery disease. The surgical component of the procedure is minimally invasive and can be done using robotic technology that avoids the need for sternotomy. Our objective is to study all patients who underwent robotic-assisted HCR (RHCR) to evaluate the feasibility and safety of the procedure during the establishment phase. This study is a retrospective chart review conducted at King Faisal Specialist Hospital and Research Centre in Jeddah (KFSRC-J). The study focuses on patients who underwent RHCR between July 2018 to December 2020. The study was approved by the institutional review board #2020-103. Robotic-assisted HCR was performed on 78 patients (mean age, 56 years (range, 43-72 years); 89.75% males) during the study phase. Left internal mammary artery grafting was used in all patients. There was no hospital mortality, and the mean hospital and intensive care unit (ICU) stay were 5.8 and 1.4 days, respectively. We found that 93.6% of the patients had no blood transfusion. There were no major adverse cardiac events (MACE) and perioperative MI recorded. There was a 3.8% rate of postoperative complications. The percentage of surgeries converted to conventional and re-exploration for bleeding were 1.2% and 2.6%, respectively. The average operation time was 164 min. This study emphasizes on the safety and effectiveness of RHCR in treating patients with multivessel coronary artery disease. Moreover, robotic-assisted hybrid coronary revascularization offers an alternative, functionally complete revascularization option to a selected group of patients with minimal surgical trauma, short hospital and ICU length of stay, quick recovery, and little to no blood transfusion requirement.

29 April 2026 in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
Verified
Journal Article
Closed access
SBSalman W. Bafageeh
Salman W. Bafageeh
HBHani I. Barnawi
Hani I. Barnawi
MAMohammed A. Ashour
Mohammed A. Ashour
MAMarah M. Alsulami
Marah M. Alsulami
YAYara Aljefri
Yara Aljefri
Uthman AlUthmanUthman AlUthman
Uthman AlUthman
Objective: Coronary artery disease (CAD) significantly affects patient quality of life (QoL). Robot-assisted hybrid coronary revascularization (RHCR) emerged as a minimally invasive alternative to conventional coronary artery bypass grafting (CABG), offering enhanced recovery and improved QoL outcomes. This study evaluates the QoL outcomes of RHCR compared with conventional CABG preoperatively and 4 weeks and 6 months postoperatively using the validated 36-Item Short Form (SF-36) questionnaire. Methods: This prospective study included 96 patients (48 RHCR, 48 CABG) with multivessel CAD treated at King Faisal Specialist Hospital between July 2018 and December 2020. QoL was assessed using the SF-36 questionnaire across 8 domains with scores obtained preoperatively and at 4 weeks and 6 months after surgery. Statistical analyses were conducted to compare changes between groups. Results: The RHCR group consistently reported higher scores for physical functioning and role limitations due to physical health, mental health, social functioning, and general health at all time points. At 4 weeks, RHCR patients experienced significantly better scores in physical functioning (75.4 vs 62.6, P < 0.001), social functioning (72.5 vs 64.2, P = 0.003), and bodily pain (76.8 vs 54.0, P < 0.001). At 6 months, RHCR maintained superiority in physical functioning (94.7 vs 88.0, P < 0.001), general health (84.1 vs 78.1, P = 0.020), and mental health (83.5 vs 75.4, P = 0.002). Conclusions: RHCR is associated with greater improvements in QoL compared with conventional CABG, particularly in domains related to physical functioning, role limitations due to physical health, and general health perception.